Home > News > pSivida signs licence with Beijing Med-Pharm
October 27th, 2005
pSivida signs licence with Beijing Med-Pharm
Abstract:
Global bio-nanotech company pSivida Limited is pleased to announce that it has signed a Licence with Beijing Med-Pharm Corporation for the clinical development, marketing and distribution of pSivida's lead product, BrachySilTM, in China.
Source:
biotech-intelligence.com
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||